The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.
 
Ann M. Gillenwater
Travel, Accommodations, Expenses - Aspyerian Therapeutics
 
David Cognetti
Stock and Other Ownership Interests - Statistical Innovations
Research Funding - Aspyrian Therapeutics (Inst)
 
Jennifer Maria Johnson
Consulting or Advisory Role - Foundation Medicine
 
Joseph Curry
No Relationships to Disclose
 
Samith Thomas Kochuparambil
No Relationships to Disclose
 
Darren McDonald
No Relationships to Disclose
 
Mary J. Fidler
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech (I); Takeda
Speakers' Bureau - celgene; Genentech; Merck
 
Kerstin Stenson
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Amgen (I); Biogen (I); Celgene (I); Gilead Sciences (I); Horizon Pharma (I); Intuitive Surgical (I); Isis Pharmaceuticals (I); Merck (I); Oganobo (I); Pfizer (I); Regeneron (I); Seagen (I); Teva (I)
Patents, Royalties, Other Intellectual Property - I recieve royalties for writing several "Up to Date " chapters per year
 
Nilesh Vasan
Stock and Other Ownership Interests - Adroit Surgical
Consulting or Advisory Role - Aspyrian Therapeutics
Patents, Royalties, Other Intellectual Property - Adroit Surgical; University of Oklahoma
Travel, Accommodations, Expenses - Aspyrian Therapeutics
 
Mohammad Razaq
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Aspyrian Therapeutics; AstraZeneca
Speakers' Bureau - Merck Sharp & Dohme
 
John Campana
No Relationships to Disclose
 
Frank Mott
No Relationships to Disclose